FDA Approved Medical Products for:

Fibrinogen deficiency, congenital

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Human fibrinogen concentrate, pasteurized
Trade Name
(Manufacturer Name)
RiaSTAP®
(CSL Behring, LLC)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia
More Information about this product Drug Information Portal